Literature DB >> 6169304

Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture.

P C Familletti, R McCandliss, S Pestka.   

Abstract

A myeloblast cell line has proved to be an excellent source of human leukocyte interferon. These cells, primed with interferon and induced with Sendai virus, produced optimal levels of human leukocyte interferon. The cells grew readily in spinner flasks and in medium containing horse serum. Interferon production over several months yielded an average titer of 2 X 10(5) reference units of interferon per 10(7) cells. The interferon produced by these cells appeared to be predominantly species of human leukocyte interferon. Since these cells seemed to consist of myeloblasts, it is clear that cells other than B-lymphocytes can produce leukocyte interferon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169304      PMCID: PMC181622          DOI: 10.1128/AAC.20.1.5

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Marked enhancement of interferon production in 5-bromodeoxyuridine treated human lymphoblastoid cells.

Authors:  M G Tovey; J Begon-Lours; I Gresser; A G Morris
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

2.  Production of human lymphoblastoid interferon by Namalva cells.

Authors:  K C Zoon; C E Buckler; P J Bridgen; D Gurari-Rotman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Identification of the cell multiplication inhibitory factors in interferon preparations as interferons.

Authors:  W E Stewart; I Gresser; M G Tovey; M Bandu; S Le Goff
Journal:  Nature       Date:  1976-07-22       Impact factor: 49.962

4.  Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon.

Authors:  E Knight
Journal:  Nature       Date:  1976-07-22       Impact factor: 49.962

5.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

6.  Induction and decay of human fibroblast interferon mRNA.

Authors:  R L Cavalieri; E A Havell; J Vilcek; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Production of high-titered interferon in cultures of human diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

8.  Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts.

Authors:  J S Horoszewicz; S S Leong; M Ito; L Di Berardino; W A Carter
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Large-scale production and partial purification of mouse immune interferon.

Authors:  L C Osborne; J A Georgiades; H M Johnson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

10.  Human leukocyte interferon: production, purification to homogeneity, and initial characterization.

Authors:  M Rubinstein; S Rubinstein; P C Familletti; R S Miller; A A Waldman; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

View more
  4 in total

1.  Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes.

Authors:  T A Nyman; H Tölö; J Parkkinen; N Kalkkinen
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

2.  Cell cultures producing human interferon.

Authors:  P C Familletti; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

3.  Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop.

Authors:  Nathaniel M Green; Amy Laws; Kerstin Kiefer; Liliana Busconi; You-Me Kim; Melanie M Brinkmann; Erin Hodges Trail; Kei Yasuda; Sean R Christensen; Mark J Shlomchik; Stefanie Vogel; John H Connor; Hidde Ploegh; Dan Eilat; Ian R Rifkin; Jean Maguire van Seventer; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

Review 4.  Human natural interferon-alpha producing cells.

Authors:  P Fitzgerald-Bocarsly
Journal:  Pharmacol Ther       Date:  1993-10       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.